Evidence map›Paper›PMID 16988045›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2006

Netrin-1 signaling regulates de novo protein synthesis of kappa opioid receptor by facilitating polysomal partition of its mRNA.

Nien-Pei Tsai, Jing Bi, Horace H Loh, Li-Na Wei

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Kappa opioid receptor contributes to EGF-stimulated neurite extension in development.Proceedings of the National Academy of Sciences of the United States of America · 2010
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Function and regulation of local axonal translation.Current opinion in neurobiology · 2008
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Nien-Pei TsaiDepartment of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455, USA.
Jing Bi
Horace H Loh
Li-Na Wei
Twin Cities Orthopedics · USUniversity of Minnesota Medical Center · US

Funding

Subcellular Targeting/Packaging of Opioids/ReceptorsP50DA011806 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI LOH, HORACE · 1998 to 2012
$14.0M
Studies of nuclear receptor corepressor, NRIP1, in vitamin A signaling pathwaysR01DK060521 · NIDDK · UNIVERSITY OF MINNESOTA TWIN CITIES · PI WEI, LI-NA · 2002 to 2022
$6.9M
Structural and Functions Studies of Mu Opiate Receptors: Regulation of its GeneR01DA001583 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI LOH, HORACE · 1985 to 2017
$6.5M
TR2 NUCLEAR RECEPTOR IN VITAMIN A SIGNALING PATHWAYSR01DK054733 · NIDDK · UNIVERSITY OF MINNESOTA TWIN CITIES · PI WEI, LI-NA · 1999 to 2021
$5.7M
NEUROCHEMICAL BASIS ON NARCOTIC ADDICTIONR01DA000564 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI LOH, HORACE · 1985 to 2010
$5.1M
Studies of Mouse Kappa Opioid Receptor Gene RegulationR01DA011190 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI WEI, LI-NA · 1997 to 2011
$3.3M
Studies of the Mouse Kappa Opioid Receptor GeneK02DA013926 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI WEI, LI-NA · 2002 to 2011
$1.2M
NEUROCHEMICAL MECHANISM OF NARCOTIC ACTIONSK05DA070554 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI LOH, HORACE · 1985 to 2008
$1.1M
Neurochemical Basis of Opiate AddictionR56DA000564 · NIDA · UNIVERSITY OF MINNESOTA · PI LAW, PING-YEE, LOH, HORACE · 2012 to 2013
$329k
STRUCTURAL AND FUNCTIONAL STUDIES OF MU OPIOID RECEPTORSR37DA001583 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI LOH, HORACE H · 1987 to 1996
–
NIDA NIH HHS DA00564NIDA NIH HHS DA01583NIDA NIH HHS DA11190NIDA NIH HHS DA11806NIDA NIH HHS K02 DA013926NIDA NIH HHS K02-DA13926NIDA NIH HHS K05 DA070554NIDA NIH HHS K05-DA70554NIDA NIH HHS P50 DA011806NIDA NIH HHS R01 DA000564NIDA NIH HHS R01 DA001583NIDA NIH HHS R01 DA011190NIDA NIH HHS R56 DA000564NIDDK NIH HHS DK54733NIDDK NIH HHS DK60521NIDDK NIH HHS R01 DK054733NIDDK NIH HHS R01 DK060521
6 · The paper itself

Abstract

The expression of kappa opioid receptor (KOR) is subjected to both transcriptional and posttranscriptional controls. We report that KOR translation is regulated by netrin-1 in primary neurons of dorsal root ganglion (DRG) and in P19 embryonal carcinoma cells. Without stimulation, a significant portion of KOR mRNA is maintained in a dormant state and partitions in the translationally inactive, post-polysomal fraction. During netrin-1 stimulation, which activates its downstream target focal adhesion kinase (FAK), KOR mRNA rapidly partitions to the translationally active polysomal fraction. Functionally, the newly synthesized KOR proteins in DRG neurons are able to bind to specific ligands. This report describes the first example of netrin-1 signaling in the translational control of a drug receptor KOR, which involves the mediator of netrin-1, FAK, and a novel mechanism that enhances the association of target mRNA with polysomes for translational activation.

Indexed as

AnimalsCell Line, TumorGanglia, SpinalMiceNerve Growth FactorsNetrin-1PolyribosomesProtein BiosynthesisReceptors, Opioid, kappaRNA, MessengerSignal TransductionTumor Suppressor ProteinsNerve Growth FactorsNetrin-1Ntn1 protein, mouseReceptors, Opioid, kappaRNA, MessengerTumor Suppressor Proteins

Identifiers

PMID16988045
PMCPMC6674448
OpenAlexW1980936109

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.